This compound is primarily researched for its potential effects on cannabinoid receptors, which are part of the endocannabinoid system in the body. It has been studied in laboratory settings to understand its binding affinity and interaction with CB1 and CB2 receptors, which could provide insights into the development of therapeutic agents for conditions like chronic pain, inflammation, and neurological disorders. However, due to its psychoactive properties, it is not approved for medical or recreational use and is often controlled under various legal frameworks. Its application remains limited to scientific research to explore its pharmacological properties and potential risks.